Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoshi Sugimoto

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Cellular and Molecular Life Sciences : CMLS|January 13, 2021
Generation and manipulation of human iPSC-derived plateletsNaoshi Sugimoto, Koji Eto
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 6, 2017
Development of iPS cell-derived blood products and production guidelinesNaoshi Sugimoto, Koji Eto
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 12, 2018
[Ex vivo platelet production from induced pluripotent stem cells]Naoshi Sugimoto, Koji Eto
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 9, 2022
[Clinical applications of iPS cell-derived platelets]Naoshi Sugimoto, Koji Eto
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 11, 2019
[Reconstitution of the hematopoietic system and clinical applications of iPS cells]Naoshi Sugimoto, Koji Eto
Inflammation and Regeneration|December 9, 2020
Ex vivo generation of platelet products from human iPS cellsSou Nakamura, Naoshi Sugimoto, Koji Eto
Development, Growth & Differentiation|January 28, 2021
Development of platelet replacement therapy using human induced pluripotent stem cellsSou Nakamura, Naoshi Sugimoto, Koji Eto
International Journal of Hematology|December 27, 2022
Ex vivo manufacturing of platelets: beyond the first-in-human clinical trial using autologous iPSC-plateletsSi Jing Chen, Naoshi Sugimoto, Koji Eto
Clinical Case Reports|March 26, 2021
Dual fungal infection with <i>Lomentospora prolificans</i> and <i>Aspergillus fumigatus</i>: A pathogenetic diagnosis elucidated after two decades by sequential examinationsYoshitsugu Sugiura, Naoshi Sugimoto, Takayuki Takahashi, et al.
Frontiers in Immunology|April 26, 2021
Fit-For-All iPSC-Derived Cell Therapies and Their Evaluation in Humanized Mice With NK Cell ImmunityCharlotte Flahou, Tatsuya Morishima, Hitoshi Takizawa, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Cellular and Molecular Life Sciences : CMLS|January 13, 2021
Generation and manipulation of human iPSC-derived plateletsNaoshi Sugimoto, Koji Eto
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 6, 2017
Development of iPS cell-derived blood products and production guidelinesNaoshi Sugimoto, Koji Eto
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 12, 2018
[Ex vivo platelet production from induced pluripotent stem cells]Naoshi Sugimoto, Koji Eto
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 9, 2022
[Clinical applications of iPS cell-derived platelets]Naoshi Sugimoto, Koji Eto
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 11, 2019
[Reconstitution of the hematopoietic system and clinical applications of iPS cells]Naoshi Sugimoto, Koji Eto
Inflammation and Regeneration|December 9, 2020
Ex vivo generation of platelet products from human iPS cellsSou Nakamura, Naoshi Sugimoto, Koji Eto
Development, Growth & Differentiation|January 28, 2021
Development of platelet replacement therapy using human induced pluripotent stem cellsSou Nakamura, Naoshi Sugimoto, Koji Eto
International Journal of Hematology|December 27, 2022
Ex vivo manufacturing of platelets: beyond the first-in-human clinical trial using autologous iPSC-plateletsSi Jing Chen, Naoshi Sugimoto, Koji Eto
Clinical Case Reports|March 26, 2021
Dual fungal infection with <i>Lomentospora prolificans</i> and <i>Aspergillus fumigatus</i>: A pathogenetic diagnosis elucidated after two decades by sequential examinationsYoshitsugu Sugiura, Naoshi Sugimoto, Takayuki Takahashi, et al.
Frontiers in Immunology|April 26, 2021
Fit-For-All iPSC-Derived Cell Therapies and Their Evaluation in Humanized Mice With NK Cell ImmunityCharlotte Flahou, Tatsuya Morishima, Hitoshi Takizawa, et al.
Pageof 4